Investors
Nerveda is a privately funded, life science organization dedicated to advancing novel therapeutic and diagnostic technologies for neurodegenerative diseases. The company was established by senior life science executives, experienced angel investors and leading scientists in the field of neurology. By bringing together these key stakeholders the company is able to identify, evaluate, finance and develop novel strategies in areas of high unmet medical need. Our primary focus, initially, is the development of a blood based, molecular diagnostic test for multiple sclerosis which will complement other programs and organizations which Nerveda is supporting for the development of new therapies to treat a variety of demylenating diseases.
